Shandong Freda Biotech Co., Ltd. and its medical-aesthetic skincare brand Key C announced the presentation of a novel ...
Huonslab files BLA for HYDIZYME™, targeting MFDS approval in 2026 for its recombinant human hyaluronidase using HyDIFFUZE™.
Applying HyDIFFUZE technology, aiming for Approval by MFDS in 2026 Huonslab, a subsidiary of Huons Global (KOSDAQ:084110), has submitted a Biologics License Application (BLA) to the Ministry of ...
Discover how artificial intelligence is transforming influenza vaccine development, accelerating timelines and improving ...
GC Biopharma (006280.KS), a leading global biopharmaceutical company, today announced the first shipment of BARYTHRAX inj., the world's first recombinant anthrax vaccine. The product, jointly ...
Dyadic Applied BioSolutions ('Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...
COO Marshall Bredwell says Perfect Day is "confident in instant profitability at plant launch" for its precision fermentation ...
Canine induced pluripotent stem (iPS) cells possess the ability to differentiate into any type of cell, making them a useful tool for investigating common canine diseases and disease states, including ...
All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.
Avatar: Fire and Ash brings back Jake Sully, but he's not the focus of the story. Instead, a character introduced in The Way ...
She had been working with refugees and channeled her anger over their situation into the ferocious performance, which was ...